China’s Churning Out Revolutionary Cancer Drugs Much Cheaper Than the U.S.
An employee examines vials of adrenaline hydrochloride injection solution at a China Grand Pharmaceutical and Healthcare Holdings Ltd. facility in Wuhan, China. (Photographer: Qilai Shen/Bloomberg)

China’s Churning Out Revolutionary Cancer Drugs Much Cheaper Than the U.S.

(Bloomberg Businessweek) -- Western companies last year began selling some of their hottest cancer drugs, called PD-1 inhibitors, with much fanfare in China. But rather than quickly conquering the ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.